Daymark Wealth Partners’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
Other funds holding FBT
BFG
Daymark Wealth Partners's FBT Position: Q1 2026 in Review
Daymark Wealth Partners increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 476% in Q1 2026, buying an estimated $5.78M and bringing the position to 33,836 shares worth $6.79M. The position accounts for 0.21% of the portfolio, ranked #91.
Daymark Wealth Partners first reported a position in FBT in Q4 2022 and has held it in 14 quarters since. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.
- Daymark Wealth Partners held 33,836 shares of First Trust NYSE Arca Biotechnology Index Fund worth $6.79M as of Q1 2026.
- Daymark Wealth Partners bought 27,964 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2026, an estimated $5.78M.
- First Trust NYSE Arca Biotechnology Index Fund made up 0.21% of Daymark Wealth Partners's portfolio in Q1 2026, its #91 holding.
- Daymark Wealth Partners first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2022 and has held it in 14 quarters since.
- 307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.
Based on Daymark Wealth Partners's 13F filing for Q1 2026, filed 11 May 2026.